Julie Dutil to Ovarian Neoplasms
This is a "connection" page, showing publications Julie Dutil has written about Ovarian Neoplasms.
Connection Strength
0.489
-
Ossa Gomez CA, Achatz MI, Hurtado M, Sanabria-Salas MC, Sullcahuaman Y, Ch?varri-Guerra Y, Dutil J, Nielsen SM, Esplin ED, Michalski ST, Bristow SL, Hatchell KE, Nussbaum RL, Pineda-Alvarez DE, Ashton-Prolla P. Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study. JCO Glob Oncol. 2022 07; 8:e2200104.
Score: 0.163
-
Lynce F, Schlam I, Geng X, Peshkin BN, Friedman S, Dutil J, Nahleh Z, Campos C, Ricker C, Rodriguez P, Denduluri N, Ahn J, Isaacs C, Graves KD. BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. J Genet Couns. 2021 04; 30(2):383-393.
Score: 0.144
-
Dutil J, Golubeva VA, Pacheco-Torres AL, Diaz-Zabala HJ, Matta JL, Monteiro AN. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat. 2015 Dec; 154(3):441-53.
Score: 0.103
-
August EM, Quinn GP, Perales R, Closser Z, Dutil J, Puig M, Vadaparampil ST. Important considerations for recruiting women to cancer genetics studies in Puerto Rico. J Cancer Educ. 2012 Mar; 27(1):105-11.
Score: 0.079